Genotype, Phenotype, and Dominance

A gene is a segment of DNA that specifies a heritable trait, typically by encoding a protein. In diploid organisms, each individual carries two copies of every gene (one inherited from each parent), located at the same position, or locus, on homologous chromosomes. These two copies may be identical or may differ in DNA sequence; alternative sequence versions of the same gene are called alleles. The genotype of an organism is the specific combination of alleles it carries at one or more loci—for example, Bb at a seed-color locus. The phenotype is the observable, measurable outcome of that genotype: the actual color, shape, height, enzyme activity, or disease status that results, produced through the combined action of the genotype, cellular machinery, developmental processes, and often the environment. The critical conceptual move—the one Mendel made and geneticists still lean on constantly—is that genotype and phenotype are not synonyms and do not stand in a one-to-one relationship. An organism with genotype BB (homozygous dominant) and one with genotype Bb (heterozygous) can display the identical phenotype, while only careful breeding (or, today, direct DNA sequencing) can distinguish them. This is precisely why phenotype-based prediction of genotype requires special tools like the test cross, and why "looks normal" is not the same claim as "carries no recessive disease allele."

Dominance describes the rule by which a heterozygote's phenotype is determined when two different alleles are both present. An allele is dominant if its phenotypic effect is expressed whenever at least one copy is present—in both the homozygous (AA) and heterozygous (Aa) states. An allele is recessive if its effect is masked in the heterozygote and appears only when homozygous (aa). By convention, the dominant allele is given an uppercase letter and the recessive a lowercase letter of the same letter (e.g., A/*a*), a notation Mendel himself essentially invented. It is essential to note immediately, and to correct as a standing misconception, that dominance is a statement about phenotypic expression relative to a specific other allele at the same locus—it is not a statement about which allele is more common in a population, more "powerful," or more evolutionarily advanced.

Step 1 — DNA sequence differences create alleles. A gene's DNA sequence is transcribed into mRNA and translated into a protein. Alleles differ from one another because of mutations—single nucleotide changes, insertions, deletions, or larger rearrangements—that alter the coding sequence, the amino-acid sequence, and potentially the protein's function. A "wild-type" allele commonly encodes a fully functional protein (for instance, a working enzyme); a mutant allele may encode a protein with reduced, absent, or altered activity.

Step 2 — Both alleles in a heterozygote are transcribed and translated (in most cases). In a heterozygous cell, both the dominant and recessive alleles are typically present on homologous chromosomes and both can be transcribed. The dominance relationship is decided not at the level of DNA but at the level of the gene products and the cellular pathways they participate in.

Step 3 — Why one allele "wins": the molecular logic of dominance. The most common and best-understood mechanism is haplosufficiency. Many genes encode enzymes that catalyze a step in a metabolic pathway, and cells often need only a fraction of the maximum possible enzyme activity to produce a normal phenotype. If the functional allele alone (from one chromosome) produces enough enzyme to complete the pathway, then a heterozygote (one functional allele + one non-functional, or "null," allele) still makes enough product for a wild-type phenotype. The functional allele is therefore dominant, and the loss-of-function allele is recessive because its effect is invisible unless both copies are non-functional and no product at all is made. Classic examples:

• In Mendel's peas, the allele for round seed shape encodes a functional starch-branching enzyme; one working copy suffices to produce round seeds, so round is dominant over wrinkled.
• In humans, many inborn errors of metabolism (e.g., phenylketonuria, Tay-Sachs disease) are recessive precisely because a single functional copy of the relevant enzyme gene is enough to metabolize the substrate normally; disease appears only when both copies are defective.

Other molecular routes to dominance exist and are worth naming precisely, since "dominant" does not always mean "loss-of-function is recessive":

• Dominant-negative alleles: a mutant protein interferes with the function of the normal protein made from the other allele (e.g., by forming non-functional complexes), so even one mutant copy disrupts the phenotype.
• Gain-of-function dominant alleles: a mutation creates a new, harmful activity (not merely a loss of the old one), so a single copy is sufficient to cause an abnormal phenotype (e.g., Huntington disease, caused by an expanded, toxic protein).
• Haploinsufficiency: occasionally one functional copy is not enough, and the loss-of-function allele behaves as dominant because 50% gene product is insufficient for normal function.

Step 4 — From genotype to phenotype at the organism level. Cells throughout the body carry the same genotype (barring somatic mutation), but the phenotype is realized through developmental and physiological processes: gene expression is regulated in specific tissues and times, gene products interact with other proteins and with environmental inputs (nutrition, temperature, light), and the final observable trait emerges from this whole cascade—not from the genotype alone. This is why the environment can modify expressivity and penetrance of a genotype, a nuance introduced here and expanded later in the study of gene interaction and epistasis.

The dominance concept was not derived from molecular biology—it was discovered decades before DNA's role was known, through carefully quantified breeding experiments. Gregor Mendel, an Augustinian friar working in the monastery garden at Brno (in what is now the Czech Republic), conducted systematic hybridization experiments on the garden pea, Pisum sativum, between roughly 1856 and 1863, publishing his results in 1866 in "Versuche über Pflanzen-Hybriden" ("Experiments on Plant Hybrids").

What Mendel did. He selected seven traits that each existed in two clearly distinguishable, true-breeding forms—for example, seed shape (round vs. wrinkled), seed color (yellow vs. green), flower color (purple vs. white), and plant height (tall vs. short). He first established true-breeding (homozygous) parental lines by allowing self-fertilization over multiple generations and confirming that offspring always resembled the parent. He then cross-pollinated plants differing in a single trait—for instance, true-breeding round-seeded plants with true-breeding wrinkled-seeded plants—to produce a first filial generation, the F1. Critically, he counted large numbers of offspring rather than relying on impressions, a methodological innovation that made his conclusions statistically defensible.

What he observed.

Across all seven traits Mendel studied, the F1 generation showed only one of the two parental forms—the wrinkled trait did not blend with round to make an intermediate seed, and it did not simply vanish. When Mendel allowed the F1 plants to self-fertilize, the "hidden" trait reappeared in the F2 generation in a consistent ratio of approximately 3:1 (dominant-appearing : recessive-appearing offspring).

What this proved. Mendel reasoned that each pea plant carries two hereditary "factors" (what we now call alleles) for each trait, one from each parent, and that these factors do not blend but instead retain their distinct identity across generations—directly contradicting the then-dominant "blending inheritance" model, which predicted that hybrid offspring should show intermediate traits that stay intermediate forever. Mendel further reasoned that when two different factors are present together in the F1, one—the dominant factor—is expressed while the other—the recessive factor—is present but silent, only to reappear when two copies of it come together again in the F2. The reappearance of the wrinkled trait, at a stable and repeatable ~3:1 ratio, was the direct empirical proof that recessive factors are not lost or destroyed by mixing—they are carried, unaltered, in the heterozygote genotype and simply not expressed in the phenotype. This is the founding evidence for the entire genotype/phenotype/dominance framework, later validated and explained mechanistically by the chromosome theory of inheritance and, still later, by molecular biology's account of gene expression. It is worth noting explicitly, as good scientific practice, that Mendel's reported ratios are suspiciously close to the theoretical 3:1 expectation across all seven traits—a statistical concern first raised by R. A. Fisher in 1936, who suggested the data may have been unconsciously (or consciously) smoothed toward the expected ratio, possibly by an assistant. This does not overturn Mendel's conclusions, which have been independently confirmed many times over with modern statistical methods and molecular evidence, but it is a genuine and often-discussed caveat in the history of the experiment.

Example 1 — A genetics cross with an asymmetric F2 phenotype count. In pea plants, tall (T) is dominant over short (t). A true-breeding tall plant is crossed to a true-breeding short plant, producing an F1 that is self-fertilized to produce an F2 generation of 640 total plants. Step 1: Genotypes. P: TT × tt → F1: all Tt (tall, since T is dominant) Step 2: F1 self-cross Punnett square (Tt × Tt):

Genotypic ratio: 1 TT : 2 Tt : 1 tt Phenotypic ratio: 3 tall : 1 short Step 3: Apply to 640 plants. Expected tall = 3/4 × 640 = 480 Expected short = 1/4 × 640 = 160 Step 4: Suppose the actual count is 468 tall and 172 short (a realistic, slightly asymmetric real-data outcome due to chance). Compare to expectation using a chi-square test: χ² = Σ (observed − expected)² / expected χ² = (468−480)²/480 + (172−160)²/160 χ² = (144/480) + (144/160) χ² = 0.30 + 0.90 = 1.20 With 1 degree of freedom, the critical χ² value at p = 0.05 is 3.84. Since 1.20 < 3.84, the deviation is not statistically significant, and the data are consistent with simple dominant/recessive Mendelian inheritance at a single locus—illustrating how real experimental counts rarely hit the exact theoretical ratio but still support the underlying genotype-to-phenotype model.

Example 2 — A clinical pedigree reasoning problem (autosomal recessive disease). Cystic fibrosis (CF) is caused by loss-of-function mutations in the CFTR gene and is inherited as an autosomal recessive trait: only individuals homozygous for a non-functional allele (genotype cc) show disease phenotype; heterozygotes (Cc) are unaffected carriers, because one functional CFTR copy produces enough functional chloride-channel protein for essentially normal phenotype (haplosufficiency). A genetic counselor sees a couple, neither of whom has CF, who already have one child with CF. What is the probability their next child will have CF, and what does this reveal about the parents' genotypes even though both parents are phenotypically normal? Step 1: Deduce parental genotypes from the affected child. Since the child has CF (genotype cc), the child must have inherited one c allele from each parent. Since both parents are phenotypically unaffected, neither parent can be cc. Therefore both parents must be heterozygous carriers: Cc × Cc. This is the central lesson of the genotype/phenotype distinction in clinical genetics: an unaffected phenotype does not rule out carrying a recessive disease allele. Step 2: Punnett square (Cc × Cc):

Genotypic ratio: 1 CC : 2 Cc : 1 cc Phenotypic ratio: 3 unaffected : 1 affected Step 3: Probability the next child has CF = 1/4 = 25%. Step 4: Extension—probability an unaffected sibling of the affected child is a carrier. Among unaffected offspring (CC, Cc, Cc — three genotypic classes, since cc is excluded), 2 out of 3 are heterozygous carriers. So an unaffected sibling has a 2/3 chance of being a Cc carrier, a number of real importance in genetic counseling and in estimating recurrence risk for future generations—illustrating precisely why a normal phenotype and a "carrier-free" genotype are not the same claim.

Gregor Johann Mendel was born in 1822 in Heinzendorf, a village in the Austrian Empire (now Hynčice, Czech Republic), to a family of farmers. He entered the Augustinian monastery of St. Thomas in Brno in 1843, partly because monastic life offered him access to education and a scientific community he could not otherwise afford. He studied at the University of Vienna from 1851 to 1853, where he was trained in physics, chemistry, and plant physiology—a background that likely shaped his unusually quantitative, hypothesis-testing approach to biology, in contrast to the more descriptive natural history typical of his era. Returning to Brno, Mendel spent roughly eight years conducting controlled pea-breeding experiments in the monastery garden, meticulously tracking seven distinct traits across tens of thousands of individual plants, and applying arithmetic ratio analysis to biological inheritance for essentially the first time. He presented his results to the Natural History Society of Brno in 1865 and published them in 1866. His work went largely unrecognized during his lifetime—cited only a handful of times before 1900—partly because it was published in a relatively obscure regional journal, and partly because the broader scientific community lacked the conceptual framework (chromosomes, cell theory of heredity) to appreciate its significance. Mendel became abbot of his monastery in 1868, and administrative duties increasingly displaced his scientific work. He died in 1884, unaware that his findings would eventually become the foundation of modern genetics.

The genotype/phenotype distinction and dominance framework are not historical curiosities—they are load-bearing concepts in modern medicine, agriculture, and biotechnology. In clinical genetics, carrier screening panels for diseases like cystic fibrosis, sickle-cell disease, and Tay-Sachs disease exist precisely because heterozygous carriers are phenotypically normal; distinguishing genotype from phenotype through DNA testing, rather than physical examination, allows couples to assess recurrence risk before or during pregnancy, exactly as illustrated in the worked example above. In pharmacogenomics, dominance logic explains why some drug-metabolizing enzyme deficiencies only manifest in homozygotes: a patient heterozygous for a loss-of-function allele in a cytochrome P450 gene may metabolize a drug normally, while a homozygous patient may experience toxic drug accumulation—directly informing personalized dosing. In agriculture and plant breeding, breeders exploit dominance relationships to introduce disease-resistance alleles into crop varieties efficiently; because many resistance alleles are dominant, a single copy introduced by crossing can confer resistance in the very next generation, without requiring the trait to be bred to homozygosity first—a major time-saving lever in crop improvement programs. In conservation genetics, understanding that recessive deleterious alleles can persist hidden in heterozygous carriers within small populations helps explain inbreeding depression: as population size shrinks and relatives mate more often, previously rare homozygous recessive genotypes become more frequent, exposing harmful recessive phenotypes that had been masked for generations—a direct, population-scale consequence of the same genotype/phenotype gap Mendel first documented in a garden of peas.

Ask the tutor: How would the genotype-phenotype-dominance framework need to change if a trait were controlled by two genes instead of one?